BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32661800)

  • 1. Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis.
    Rumberger BE; Boarder EL; Owens SL; Howell MD
    Inflamm Res; 2020 Oct; 69(10):967-973. PubMed ID: 32661800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High inflammation in hidradenitis suppurativa extends to perilesional skin and can be subdivided by lipocalin-2 expression.
    Navrazhina K; Garcet S; Zheng X; Hur HB; Frew JW; Krueger JG
    J Allergy Clin Immunol; 2022 Jan; 149(1):135-144.e12. PubMed ID: 34081946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary alterations during the development of hidradenitis suppurativa.
    Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 5. IL-17A is a pertinent therapeutic target for moderate-to-severe hidradenitis suppurativa: Combined results from a pre-clinical and phase II proof-of-concept study.
    Kimball AB; Loesche C; Prens EP; Bechara FG; Weisman J; Rozenberg I; Jarvis P; Peters T; Roth L; Wieczorek G; Kolbinger F; Jemec GBE
    Exp Dermatol; 2022 Oct; 31(10):1522-1532. PubMed ID: 35638561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.
    Vossen ARJV; Ardon CB; van der Zee HH; Lubberts E; Prens EP
    Br J Dermatol; 2019 Aug; 181(2):314-323. PubMed ID: 30657173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies.
    Liu H; Santos LL; Smith SH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.
    Kelly G; Hughes R; McGarry T; van den Born M; Adamzik K; Fitzgerald R; Lawlor C; Tobin AM; Sweeney CM; Kirby B
    Br J Dermatol; 2015 Dec; 173(6):1431-9. PubMed ID: 26282467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tape strips detect molecular alterations and cutaneous biomarkers in skin of patients with hidradenitis suppurativa.
    Navrazhina K; Renert-Yuval Y; Khattri S; Hamade H; Meariman M; Andrews E; Kim M; NandyMazumdar M; Gour DS; Bose S; Williams SC; Garcet S; Correa da Rosa J; Gottlieb AB; Krueger JG; Guttman-Yassky E
    J Am Acad Dermatol; 2024 Apr; 90(4):749-758. PubMed ID: 38049071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa.
    Saraç Öztürk G; Ergun T; Peker Eyüboğlu İ; Akkiprik M
    Cytokine; 2021 Aug; 144():155585. PubMed ID: 34034145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study.
    van der Zee HH; Laman JD; de Ruiter L; Dik WA; Prens EP
    Br J Dermatol; 2012 Feb; 166(2):298-305. PubMed ID: 22013960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β.
    van der Zee HH; de Ruiter L; van den Broecke DG; Dik WA; Laman JD; Prens EP
    Br J Dermatol; 2011 Jun; 164(6):1292-8. PubMed ID: 21332464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis.
    Gudjonsson JE; Tsoi LC; Ma F; Billi AC; van Straalen KR; Vossen ARJV; van der Zee HH; Harms PW; Wasikowski R; Yee CM; Rizvi SM; Xing X; Xing E; Plazyo O; Zeng C; Patrick MT; Lowe MM; Burney RE; Kozlow JH; Cherry-Bukowiec JR; Jiang Y; Kirma J; Weidinger S; Cushing KC; Rosenblum MD; Berthier C; MacLeod AS; Voorhees JJ; Wen F; Kahlenberg JM; Maverakis E; Modlin RL; Prens EP
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32853177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell transcriptomics suggest distinct upstream drivers of IL-17A/F in hidradenitis versus psoriasis.
    Kim J; Lee J; Li X; Lee HS; Kim K; Chaparala V; Murphy W; Zhou W; Cao J; Lowes MA; Krueger JG
    J Allergy Clin Immunol; 2023 Sep; 152(3):656-666. PubMed ID: 37271319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
    Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
    Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
    Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
    Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
    Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
    PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.
    Fletcher JM; Moran B; Petrasca A; Smith CM
    Clin Exp Immunol; 2020 Aug; 201(2):121-134. PubMed ID: 32379344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin.
    Coates M; Mariottoni P; Corcoran DL; Kirshner HF; Jaleel T; Brown DA; Brooks SR; Murray J; Morasso MI; MacLeod AS
    PLoS One; 2019; 14(5):e0216249. PubMed ID: 31059533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.